Corcept Therapeutics | CORT - Market Capitalization

Stock Price
56.37
Daily Change
-1.93 -3.31%
Monthly
28.23%
Yearly
-24.92%
Q2 Forecast
55.24

Corcept Therapeutics reported $6.03B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 221M May/2026
Alaunos Therapeutics USD 5M 5M Sep/2025
ANI Pharmaceuticals USD 1.69B 57M May/2026
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Canopy Growth CAD 656.46M 124.89M Dec/2025
Corcept Therapeutics USD 4.32B 654M Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Esperion Therapeutics USD 885M 351M Dec/2025
J&J USD 579.15B 78.91B Mar/2026
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Merck USD 297.1B 35.84B Mar/2026
Nektar Therapeutics USD 15.62B 14.76B May/2026
Novartis USD 232.75B 75B May/2026
Pacira USD 915M 149M Mar/2026
Pfizer USD 147.4B 6.42B May/2026
Supernus Pharmaceuticals USD 2.82B 155M May/2026
TG Therapeutics USD 6.48B 1.18B May/2026